- Home
- SNTI vs JVA Comparison
SNTI vs JVA Comparison
Compare SNTI & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- JVA
- Stock Information
- Founded
- SNTI 2016
- JVA 1971
- Country
- SNTI United States
- JVA United States
- Employees
- SNTI N/A
- JVA N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- SNTI Health Care
- JVA Consumer Staples
- Exchange
- SNTI Nasdaq
- JVA Nasdaq
- Market Cap
- SNTI 85.3M
- JVA 24.7M
- IPO Year
- SNTI N/A
- JVA 2005
- Fundamental
- Price
- SNTI $2.21
- JVA $4.50
- Analyst Decision
- SNTI Strong Buy
- JVA
- Analyst Count
- SNTI 2
- JVA 0
- Target Price
- SNTI $8.50
- JVA N/A
- AVG Volume (30 Days)
- SNTI 380.4K
- JVA 227.0K
- Earning Date
- SNTI 08-12-2025
- JVA 06-13-2025
- Dividend Yield
- SNTI N/A
- JVA N/A
- EPS Growth
- SNTI N/A
- JVA 856.08
- EPS
- SNTI N/A
- JVA 0.65
- Revenue
- SNTI N/A
- JVA $84,651,329.00
- Revenue This Year
- SNTI N/A
- JVA N/A
- Revenue Next Year
- SNTI $150.00
- JVA N/A
- P/E Ratio
- SNTI N/A
- JVA $6.97
- Revenue Growth
- SNTI N/A
- JVA 15.86
- 52 Week Low
- SNTI $1.52
- JVA $1.50
- 52 Week High
- SNTI $16.94
- JVA $9.93
- Technical
- Relative Strength Index (RSI)
- SNTI 43.19
- JVA 57.42
- Support Level
- SNTI $2.10
- JVA $4.15
- Resistance Level
- SNTI $2.43
- JVA $4.54
- Average True Range (ATR)
- SNTI 0.18
- JVA 0.28
- MACD
- SNTI 0.05
- JVA -0.01
- Stochastic Oscillator
- SNTI 79.25
- JVA 61.54
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.